Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Analyzing Pharmacy Benefits in Value-Based Oncology Pathways

James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways Congress.

Advertisement

Advertisement

Advertisement